Literature DB >> 27701774

Thyroid eye disease: a review.

Danielle L Weiler1,2.   

Abstract

Thyroid eye disease is a multifactorial autoimmune disease with a spectrum of signs and symptoms. Oftentimes, the diagnosis of thyroid eye disease is straightforward, based upon history and physical examination. The purpose of this review is to assist the eye-care practitioner in staging the severity of thyroid eye disease (mild, moderate-to-severe and sight-threatening) and correlating available treatment modalities. Eye-care practitioners play an important role in the multidisciplinary team by assessing functional vision while also managing ocular health.
© 2016 Optometry Australia.

Entities:  

Keywords:  Graves’ ophthalmopathy; Graves’ orbitopathy; thyroid eye disease

Mesh:

Year:  2016        PMID: 27701774     DOI: 10.1111/cxo.12472

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  21 in total

Review 1.  Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment.

Authors:  Faraat Ali; Anushma Chorsiya; Varisha Anjum; Asad Ali
Journal:  Int Ophthalmol       Date:  2021-01-22       Impact factor: 2.031

2.  The effect of intravenous high-dose glucocorticoids and orbital decompression surgery on sight-threatening thyroid-associated ophthalmopathy.

Authors:  Yun Wen; Jian-Hua Yan
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

3.  Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results.

Authors:  Mehmet Ozgur Cubuk; Onur Konuk; Mehmet Unal
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

4.  BIOINFORMATIC ANALYSIS IDENTIFIES POTENTIALLY KEY DIFFERENTIALLY EXPRESSED GENES AND PATHWAYS IN ORBITAL ADIPOSE TISSUES OF PATIENTS WITH THYROID EYE DISEASE.

Authors:  F F Zhu; L Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

5.  Usefulness of readout-segmented EPI-based diffusion tensor imaging of lacrimal gland for detection and disease staging in thyroid-associated ophthalmopathy.

Authors:  Lu Chen; Hao Hu; Wen Chen; Qian Wu; Jiang Zhou; Huan-Huan Chen; Xiao-Quan Xu; Hai-Bin Shi; Fei-Yun Wu
Journal:  BMC Ophthalmol       Date:  2021-07-20       Impact factor: 2.209

6.  Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease.

Authors:  Rong-Hua Song; Qian Li; Wen Wang; Qiu-Ming Yao; Xiao-Qing Shao; Jin-An Zhang
Journal:  Int J Endocrinol       Date:  2017-08-03       Impact factor: 3.257

7.  Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging.

Authors:  Ahmed Abdel Razek; El-Hadidy Mohamed El-Hadidy; Mohamed El-Said Moawad; Nader El-Metwaly; Amr Abd El-Hamid El-Said
Journal:  Pol J Radiol       Date:  2019-03-08

8.  Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.

Authors:  Zhihong Deng; Lu Chen; Jia Tan; Sha Wang; Dan Liu; Jinwei Wang; Chengzhi Jiang; Jie Yang; Bei Xu
Journal:  Dis Markers       Date:  2021-05-18       Impact factor: 3.434

9.  Treatment of Graves' ophthalmopathy with an in-house Phosphorus-32 source: Initial clinical observations.

Authors:  Hai-Tao Hao; Yujun Wang; Xufu Wang; Sha Luan; Jianhua Cui; Yu Chen; Ya-Li Cui
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

10.  The Cerebellum Posterior Lobe Associates with the Exophthalmos of Primary Hyperthyroidism: A Resting-State fMRI Study.

Authors:  Wen-Feng Liu; Yong-Qiang Shu; Pei-Wen Zhu; Biao Li; Wen-Qing Shi; Qi Lin; Yu-Xin Liu; Meng-Yao Zhang; You-Lan Min; Qing Yuan; Yi Shao
Journal:  Int J Endocrinol       Date:  2019-11-28       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.